{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:46Z","timestamp":1790393626279,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background and Purpose:<\/jats:title>\n            <jats:p>We determined the rates and predictors of acute kidney injury (AKI) and renal adverse events (AEs), and effects of AKI and renal AEs on death or disability in patients with intracerebral hemorrhage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We analyzed data from a multicenter trial which randomized 1000 intracerebral hemorrhage patients with initial systolic blood pressure \u2265180 mm Hg to intensive (goal 110\u2013139 mm Hg) over standard (goal 140\u2013179 mm Hg) systolic blood pressure reduction within 4.5 hours of symptom onset. AKI was identified by serial assessment of daily serum creatinine for 3 days post randomization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>AKI and renal AEs were observed in 149 patients (14.9%) and 65 patients (6.5%) among 1000 patients, respectively. In multivariate analysis, the higher baseline serum creatinine (\u2265110 \u03bcmol\/L) was associated with AKI (odds ratio 2.4 [95% CI, 1.2\u20134.5]) and renal AEs (odds ratio 3.1 [95% CI, 1.2\u20138.1]). Higher area under the curve for intravenous nicardipine dose was associated with AKI (odds ratio 1.003 [95% CI, 1.001\u20131.005]) and renal AEs (odds ratio 1.003 [95% CI, 1.001\u20131.006]). There was a higher risk to death (relative risk 2.6 [95% CI, 1.6\u20134.2]) and death or disability (relative risk 1.5 [95% CI, 1.3\u20131.8]) at 90 days in patients with AKI but not in those with renal AEs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Intracerebral hemorrhage patients with higher baseline serum creatinine and those receiving higher doses of nicardipine were at higher risk for AKI and renal AEs. Occurrence of AKI was associated higher rates of death or disability at 3 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration:<\/jats:title>\n            <jats:p>\n              URL:\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\">https:\/\/clinicaltrials.gov<\/jats:ext-link>\n              . Unique identifier: NCT01176565.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/strokeaha.120.030272","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T18:01:01Z","timestamp":1601316061000},"page":"3030-3038","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":46,"title":["Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage"],"prefix":"10.1161","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct01176565","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Adnan I.","family":"Qureshi","sequence":"first","affiliation":[{"name":"Zeenat Qureshi Stroke Institute, and Department of Neurology, University of Missouri-Columbia (A.I.Q., W.H., I.L.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Zeenat Qureshi Stroke Institute, and Department of Neurology, University of Missouri-Columbia (A.I.Q., W.H., I.L.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-6555","authenticated-orcid":true,"given":"Iryna","family":"Lobanova","sequence":"additional","affiliation":[{"name":"Zeenat Qureshi Stroke Institute, and Department of Neurology, University of Missouri-Columbia (A.I.Q., W.H., I.L.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-4258","authenticated-orcid":true,"given":"Daniel F.","family":"Hanley","sequence":"additional","affiliation":[{"name":"The Neurology Department of Johns Hopkins University, Baltimore, MD (D.F.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung Y.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan (C.Y.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3209-8140","authenticated-orcid":true,"given":"Kunal","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University of Missouri-Columbia. (K.M.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5080-8222","authenticated-orcid":true,"given":"Thorsten","family":"Steiner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Klinikum Frankfurt H\u00f6chst, Germany (T.S.)."},{"name":"Department of Neurology, Heidelberg University Hospital, Germany (T.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I.","family":"Suarez","sequence":"additional","affiliation":[{"name":"Division of Neurosciences Critical Care, The Johns Hopkins University School of Medicine, Baltimore, MD (J.I.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8346-9845","authenticated-orcid":true,"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. (K.T.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-2547","authenticated-orcid":true,"given":"Haruko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center, Suita, Japan. (H.Y.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of Antihypertensive Treatment of Cerebral Hemorrhage 2 Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000479338"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000069"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.09.031"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603460"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.008439"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-017-0488-2"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/2396987319863606"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-011-9538-3"},{"key":"e_1_3_4_10_2","first-page":"6","article-title":"Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial.","volume":"5","author":"Qureshi A","year":"2012","unstructured":"Qureshi, A, Palesch, Y; ATACH II Investigators. Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial. J Vasc Interv Neurol. 2012;5(supp):6\u20139.","journal-title":"J Vasc Interv Neurol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.019845"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.9.824"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc6997"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1385\/NCC:1:1:53"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000208408.98482.99"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.32.4.891"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2015.11.4.339"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.26.10.1764"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1085-0"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.11.028"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000145180.38707.84"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1993.265.3.F391"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.000758"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198609000-00002"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X17725431"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.004672"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc6863"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000337487"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.12.033"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002485"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4670-3"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.10.009"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.285063"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000581"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.120.030272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:09:31Z","timestamp":1715612971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.120.030272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1161\/STROKEAHA.120.030272"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.120.030272","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"2020-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}